Northern Trust Corp Applied Genetic Technologies Corp Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.1 $6 - $11	-10 Reduced 0.01%	75,255 $58,000
Q4 2021 Feb 08, 2022	SELL	$1.87 - $2.91 $1,122 - $1,746	-600 Reduced 0.79%	75,265 $143,000
Q3 2021 Nov 15, 2021	BUY	$3.01 - $4.12 $1,805 - $2,472	600 Added 0.8%	75,865 $228,000
Q2 2021 Aug 13, 2021	SELL	$3.62 - $5.23 $1.18 Million - $1.7 Million	-325,747 Reduced 81.23%	75,265 $294,000
Q1 2021 May 12, 2021	BUY	$3.94 - $8.19 $544,228 - $1.13 Million	138,129 Added 52.54%	401,012 $2.03 Million
Q4 2020 Feb 11, 2021	BUY	$3.99 - $5.7 $14,970 - $21,386	3,752 Added 1.45%	262,883 $1.08 Million
Q3 2020 Nov 16, 2020	BUY	$4.38 - $6.43 $751,905 - $1.1 Million	171,668 Added 196.27%	259,131 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$3.0 - $6.9 $177,957 - $409,301	59,319 Added 210.77%	87,463 $485,000
Q1 2020 May 14, 2020	BUY	$2.36 - $9.86 $17,867 - $74,650	7,571 Added 36.8%	28,144 $92,000
Q4 2017 Feb 14, 2018	SELL	$3.4 - $4.15 $1,961 - $2,394	-577 Reduced 2.73%	20,573 $75,000
Q3 2017 Nov 13, 2017	BUY	$3.55 - $5.25 $75,082 - $111,037	21,150	21,150 $84,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.